Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01655225
Title A Study of LY3023414 in Participants With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
UCLA Medical Center Los Angeles California 90095 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City Oklahoma 73104 United States Details
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Azienda Ospedaliero - Universitaria S. Luigi Gonzaga Orbassano Torino 10043 Italy Details
Fundacion de Investigacion de Diego San Juan 00927 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field